Advances in neural circuit mechanism in Parkinson's disease

doi:10.3969/j.issn.1672-6731.2020.12.002

Abstract

Abstract:

Parkinson's disease (PD) is a common neurodegenerative disease with strong heterogeneity of clinical symptoms and progressive aggravation. The core pathological feature is the apoptosis of dopaminergic neurons in substantia nigra and striatum, but this pathological feature can only explain part of the symptom. With the development of electrophysiological recording, fMRI, optogenetics and other technologies, it has been found that neural circuit dysfunction after dopaminergic neuron apoptosis is an important mechanism for the occurrence and development of PD, as well as many therapeutic measures such as deep brain stimulation (DBS) intervention target. This article reviews the research progress of PD neural circuit mechanism in recent years, including common symptoms of PD, neural circuit models, and abnormal electrical activity patterns, to provide ideas for clinical research.

Key words: Parkinson disease, Neurons, Basal ganglia, Deep brain stimulation, Review

摘要：

帕金森病是临床常见的神经退行性疾病，临床症状异质性强，病情呈渐进性加重，其病理核心特征为黑质纹状体多巴胺能神经元凋亡，但这一病理特征仅能解释部分症状。随着神经电生理监测、fMRI、光遗传学等技术的发展，目前普遍认为，多巴胺能神经元凋亡诱发的神经环路功能障碍是帕金森病发生发展的重要机制，也是脑深部电刺激术等多种治疗措施的干预靶点。本文对近年帕金森病神经环路机制研究进展如帕金森病常见症状、神经环路模型，以及异常神经电活动模式等进行概述，以为临床研究提供思路。

关键词: 帕金森病, 神经元, 基底神经节, 深部脑刺激法, 综述

XIONG Chi, NIU Chao-shi. Advances in neural circuit mechanism in Parkinson's disease[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2020, 20(12): 1032-1036.

熊赤, 牛朝诗. 帕金森病神经环路机制研究进展[J]. 中国现代神经疾病杂志, 2020, 20(12): 1032-1036.

/ / Recommend / Download Citations

URL: https://journal11.magtechjournal.com/cjcnn/EN/10.3969/j.issn.1672-6731.2020.12.002

https://journal11.magtechjournal.com/cjcnn/EN/Y2020/V20/I12/1032

References

[1] Parkinson T. Outlines of zoonosological tables[J]. Lond Med Phys J, 1817, 38:449-453.
[2] Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease[J]. Neurobiol Aging, 2003, 24:197-211.
[3] Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V, Chesselet MF, Keshavarzian A, Shannon KM, Krajmalnik-Brown R, Wittung-Stafshede P, Knight R, Mazmanian SK. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease[J]. Cell, 2016, 167:1469-1480.
[4] Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. MDS clinical diagnostic criteria for Parkinson's disease[J]. Mov Disord, 2015, 30:1591-1601.
[5] Faivre F, Joshi A, Bezard E, Barrot M. The hidden side of Parkinson's disease:studying pain, anxiety and depression in animal models[J]. Neurosci Biobehav Rev, 2019, 96:335-352.
[6] Valkovic P, Minar M, Singliarova H, Harsany J, Hanakova M, Martinkova J, Benetin J. Pain in Parkinson's disease:a cross-sectional study of its prevalence, types, and relationship to depression and quality of life[J]. PLoS One, 2015, 10:e0136541.
[7] Robbins TW, Cools R. Cognitive deficits in Parkinson's disease:a cognitive neuroscience perspective[J]. Mov Disord, 2014, 29:597-607.
[8] Sethi K. Levodopa unresponsive symptoms in Parkinson disease[J]. Mov Disord, 2008, 23 Suppl 3:521-533.
[9] Surmeier DJ, Obeso JA, Halliday GM. Selective neuronal vulnerability in Parkinson disease[J]. Nat Rev Neurosci, 2017, 18:101-113.
[10] Seidel K, Mahlke J, Siswanto S, Krüger R, Heinsen H, Auburger G, Bouzrou M, Grinberg LT, Wicht H, Korf HW, den Dunnen W, Rüb U. The brainstem pathologies of Parkinson's disease and dementia with Lewy bodies[J]. Brain Pathol, 2015, 25:121-135.
[11] Pagano G, Niccolini F, Fusar-Poli P, Politis M. Serotonin transporter in Parkinson's disease:a Meta-analysis of positron emission tomography studies[J]. Ann Neurol, 2017, 81:171-180.
[12] Espay AJ, LeWitt PA, Kaufmann H. Norepinephrine deficiency in Parkinson's disease:the case for noradrenergic enhancement[J]. Mov Disord, 2014, 29:1710-1719.
[13] Horvath J, Herrmann FR, Burkhard PR, Bouras C, Kövari E. Neuropathology of dementia in a large cohort of patients with Parkinson's disease[J]. Parkinsonism Relat Disord, 2013, 19:864-868.
[14] Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders[J]. Trends Neurosci, 1989, 12:366-375.
[15] DeLong MR. Primate models of movement disorders of basal ganglia origin[J]. Trends Neurosci, 1990, 13:281-285.
[16] Mink JW, Thach WT. Basal ganglia intrinsic circuits and their role in behavior[J]. Curr Opin Neurobiol, 1993, 3:950-957.
[17] Mink JW. The basal ganglia:focused selection and inhibition of competing motor programs[J]. Prog Neurobiol, 1996, 50:381-425.
[18] Coudé D, Parent A, Parent M. Single-axon tracing of the corticosubthalamic hyperdirect pathway in primates[J]. Brain Struct Funct, 2018, 223:3959-3973.
[19] Kelley R, Flouty O, Emmons EB, Kim Y, Kingyon J, Wessel JR, Oya H, Greenlee JD, Narayanan NS. A human prefrontal-subthalamic circuit for cognitive control[J]. Brain, 2018, 141:205-216.
[20] Bariselli S, Fobbs WC, Creed MC, Kravitz AV. A competitive model for striatal action selection[J]. Brain Res, 2019, 1713:70-79.
[21] Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex[J]. Annu Rev Neurosci, 1986, 9:357-381.
[22] Haynes WI, Haber SN. The organization of prefrontal-subthalamic inputs in primates provides an anatomical substrate for both functional specificity and integration:implications for basal ganglia models and deep brain stimulation[J]. J Neurosci, 2013, 33:4804-4814.
[23] Lambert C, Zrinzo L, Nagy Z, Lutti A, Hariz M, Foltynie T, Draganski B, Ashburner J, Frackowiak R. Confirmation of functional zones within the human subthalamic nucleus:patterns of connectivity and sub-parcellation using diffusion weighted imaging[J]. Neuroimage, 2012, 60:83-94.
[24] Pasquereau B, DeLong MR, Turner RS. Primary motor cortex of the parkinsonian monkey:altered encoding of active movement[J]. Brain, 2016, 139(Pt 1):127-143.
[25] Yoon HH, Park JH, Kim YH, Min J, Hwang E, Lee CJ, Suh JK, Hwang O, Jeon SR. Optogenetic inactivation of the subthalamic nucleus improves forelimb akinesia in a rat model of Parkinson disease[J]. Neurosurgery, 2014, 74:533-540.
[26] Li Q, Ke Y, Chan DC, Qian ZM, Yung KK, Ko H, Arbuthnott GW, Yung WH. Therapeutic deep brain stimulation in Parkinsonian rats directly influences motor cortex[J]. Neuron, 2012, 76:1030-1041.
[27] Muralidharan A, Jensen AL, Connolly A, Hendrix CM, Johnson MD, Baker KB, Vitek JL. Physiological changes in the pallidum in a progressive model of Parkinson's disease:are oscillations enough[J]? Exp Neurol, 2016, 279:187-196.
[28] Starr PA, Rau GM, Davis V, Marks WJ Jr, Ostrem JL, Simmons D, Lindsey N, Turner RS. Spontaneous pallidal neuronal activity in human dystonia:comparison with Parkinson's disease and normal macaque[J]. J Neurophysiol, 2005, 93:3165-3176.
[29] McCairn KW, Turner RS. Pallidal stimulation suppresses pathological dysrhythmia in the parkinsonian motor cortex[J]. J Neurophysiol, 2015, 113:2537-2548.
[30] Magnin M, Morel A, Jeanmonod D. Single-unit analysis of the pallidum, thalamus and subthalamic nucleus in parkinsonian patients[J]. Neuroscience, 2000, 96:549-564.
[31] Singh A, Liang L, Kaneoke Y, Cao X, Papa SM. Dopamine regulates distinctively the activity patterns of striatal output neurons in advanced parkinsonian primates[J]. J Neurophysiol, 2015, 113:1533-1544.
[32] Pan MK, Kuo SH, Tai CH, Liou JY, Pei JC, Chang CY, Wang YM, Liu WC, Wang TR, Lai WS, Kuo CC. Neuronal firing patterns outweigh circuitry oscillations in parkinsonian motor control[J]. J Clin Invest, 2016, 126:4516-4526.
[33] Brown P, Oliviero A, Mazzone P, Insola A, Tonali P, Di Lazzaro V. Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease[J]. J Neurosci, 2001, 21:1033-1038.
[34] Deffains M, Iskhakova L, Katabi S, Israel Z, Bergman H. Longer β oscillatory episodes reliably identify pathological subthalamic activity in parkinsonism[J]. Mov Disord, 2018, 33:1609-1618.
[35] Parker T, Huang Y, Gong C, Chen Y, Wang S, Green AL, Aziz T, Li L. Pain-induced beta activity in the subthalamic nucleus of Parkinson's disease[J]. Stereotact Funct Neurosurg, 2020, 98:193-199.
[36] Swann NC, de Hemptinne C, Miocinovic S, Qasim S, Ostrem JL, Galifianakis NB, Luciano MS, Wang SS, Ziman N, Taylor R, Starr PA. Chronic multisite brain recordings from a totally implantable bidirectional neural interface:experience in 5 patients with Parkinson's disease[J]. J Neurosurg, 2018, 128:605-616.
[37] Rappel P, Grosberg S, Arkadir D, Linetsky E, Abu Snineh M, Bick AS, Tamir I, Valsky D, Marmor O, Abo Foul Y, Peled O, Gilad M, Daudi C, Ben-Naim S, Bergman H, Israel Z, Eitan R. Theta-alpha oscillations characterize emotional subregion in the human ventral subthalamic nucleus[J]. Mov Disord, 2020, 35:337-343.

Please choose a citation manager

Content to export